Skip to main content

Gefitinib Side Effects

Medically reviewed by Drugs.com. Last updated on Feb 8, 2023.

Applies to gefitinib: oral tablet.

Serious side effects of Gefitinib

Along with its needed effects, gefitinib may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking gefitinib:

Less common

Incidence unknown

Symptoms of Overdose

Get emergency help immediately if any of the following symptoms of overdose occur while taking gefitinib:

Other side effects of Gefitinib

Some side effects of gefitinib may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

Less common

For Healthcare Professionals

Applies to gefitinib: oral tablet.

Respiratory

Common (1% to 10%): Interstitial lung disease or ILD-like adverse reactions[Ref]

Hepatic

Very common (10% or more): Increased AST (up to 40%), increased ALT (up to 38%)

Common (1% to 10%): Increased bilirubin

Uncommon (0.1% to 1%): Hepatitis/hepatic failure

Rare (less than 0.1%): Fatal hepatotoxicity[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (up to 29%), nausea (up to 18%), vomiting (up to 14%)

Common (1% to 10%): Stomatitis, dry mouth, pancreatitis, dehydration (secondary to diarrhea, nausea, vomiting, or anorexia)

Uncommon (0.1% to 1%): GI perforation[Ref]

Ocular

Common (1% to 10%): Keratitis, conjunctivitis, blepharitis, dry eye

Uncommon (0.1% to 1%): Corneal erosion/aberrant eyelash growth[Ref]

Nervous system

Rare (less than 0.1%): CNS hemorrhage

Frequency not reported: Cerebrovascular events[Ref]

Dermatologic

Very common (10% or more): Skin reactions (up to 47%)

Common (1% to 10%): Nail disorder, alopecia

Rare (less than 0.1%): Bullous conditions (including toxic epidermal necrolysis, Stevens Johnson syndrome, erythema multiforme), cutaneous vasculitis[Ref]

Reported skin reactions: acne/acne pustular, dermatitis (acneiform and exfoliative), drug eruption, dry skin, erythema, folliculitis, pruritus, rash (erythematous, exfoliative, generalized, macular, maculo-papular, papular, pruritic, pustular, vesicular), skin exfoliation, skin toxicity, and xeroderma.[Ref]

Renal

Very common (10% or more): Proteinuria (up to 35%)

Common (1% to 10%): Elevated blood creatinine, cystitis

Rare (less than 0.1%): Hemorrhagic cystitis

Frequency not reported: Renal failure[Ref]

Metabolic

Very common (10% or more): Decreased appetite (up to 17%), anorexia (10%)[Ref]

Other

Very common (10% or more): Asthenia (up to 17%)

Common (1% to 10%): Pyrexia[Ref]

Hematologic

Common (1% to 10%): Hemorrhage (including epistaxis and hematuria)[Ref]

Immunologic

Common (1% to 10%): Allergic reactions (including angioedema and urticaria)[Ref]

References

1. Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals. 2003.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.